Another blood pressure drug recalled over possible cancer-causing substance

The list of blood pressure medication recalls continues to grow, because another pharmaceutical company has pulled its pills from shelves.

» RELATED: Blood pressure medication recalls: Everything you should know, Atlanta doctors, experts say

Macleods Pharmaceuticals Limited has voluntarily recalled the 100 mg/25 Losartan Potassium/Hydrochlorothiazide combination tablets, the U.S. Food and Drug Administration announced.

According to the news release, the drugs contain too much N-nitroso-diethylamine (NDEA), which has been classified as a probable human carcinogen. The recalled medications, used to control high blood pressure and heart failure, were found to have NDEA above the acceptable daily intake levels released by the FDA.

Macleods is notifying its distributors and customers and is arranging for the return of all recalled products. It is also coordinating returns with retailers, wholesalers and consumers.

Patients on the medication are advised to continue taking the tablets and to contact their doctor for advice.

“The risk of harm to a patient’s health may be higher if the treatment is stopped immediately without any comparable alternative treatment,” the company said.

This recall is the latest in the past few months. Since July, the FDA has announced voluntary recalls from Major Pharmaceuticals, Solco Healthcare, Teva Pharmaceuticals Industries and Mylan Pharmaceuticals.

See the latest recall notice here.

MORE BLOOD PRESSURE MEDICATION RECALLS

» 8 lots of blood pressure medications recalled over cancer-causing substance

» Yet another blood pressure medication recalled over cancer risk

» FDA expands recall of heart, blood pressure medication due to cancer risk

» More blood pressure medication recalled due to possible cancer risk

» Blood pressure medication recalls: Everything you should know, Atlanta doctors, experts say

» Two more blood pressure medications recalled over cancer concerns